VIVUS (VVUS) In the Spotlight Ahead of Likely FDA Obesity Drug Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/22/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. BABA
10. OSIS

Go back to VIVUS (VVUS) In the Spotlight Ahead of Likely FDA Obesity Drug Approval
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) Delayed: 99.98 --0 (-0%)
Previous Close $99.98    52 Week High $2.68 
Open $0.14    52 Week Low $1.30 
Day High $99.98    P/E N/A 
Day Low $99.98    EPS $-0.08 
Volume 21,430       

Orexigen Therapeutics, Inc. (NASDAQ: OREX) Delayed: 0.22 --0 (-0%)
Previous Close $0.22    52 Week High $4.75 
Open $0.04    52 Week Low $0.35 
Day High $0.22    P/E N/A 
Day Low $0.22    EPS $-1.02 
Volume 74,385       

Vivus, Inc. (NASDAQ: VVUS) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $1.85 
Open $44.85    52 Week Low $0.92 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $-2.13 
Volume 1,328